Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV003340824 | SCV004047581 | likely pathogenic | Glanzmann thrombasthenia 1 | criteria provided, single submitter | clinical testing | The frameshift duplication p.L855Pfs*68 in ITGA2B (NM_000419.5) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function through protein truncation caused a frameshift mutation. The frame shifted sequence continues 68 residues until a stop codon is reached. The p.L855Pfs*68 variant is a loss of function variant in the gene ITGA2B, which is intolerant of Loss of Function variants. For these reasons, this variant has been classified as Likely Pathogenic. |